🔎 Trials Near Me

Home › Edema sa Macula › Texas

Pag-aaral pangklinika para sa Edema sa Macula sa Texas

5 pag-aaral para sa Edema sa Macula ang naghahanap ng mga kalahok sa mga site sa Texas.

Mga Lungsod sa Texas

Opisyal na teksto ng pag-aaral (English)

A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-004)

  • Austin Research Center for Retina ( Site 0033), Austin
  • Austin Retina Associates ( Site 0008), Austin
  • Retina Consultants of Texas ( Site 0001), Bellaire
  • at 4 pa
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT07705555

A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-005)

  • Texas Retina ( Site 0051), Arlington
  • Texas Retina Associates ( Site 0055), Fort Worth
  • Retina Consultants of Texas - Katy/Cinco Ranch ( Site 0100), Katy
  • at 2 pa
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT07705607

A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema

  • Austin Research Center for Retina, PLLC, Austin
  • Austin Retina Associates, Austin
  • Austin Clinical Research, LLC, Austin
  • at 7 pa
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT06962839

A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PEAK

  • Retina Research Institute of Texas, Abilene
  • Austin Retina Associates, PLLC (Austin), Austin
  • UT Austin, Austin
  • at 7 pa
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update May 18, 2026 · NCT06990399

A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLE

  • Retina Research Institute of Texas, Abilene
  • Austin Retina Associates, PLLC (Austin), Austin
  • UT Austin, Austin
  • at 7 pa
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update May 18, 2026 · NCT06996080

Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.